Navigation Links
Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
Date:1/14/2013

Burlington, MA (PRWEB) January 14, 2013

Event Date: January 31, 2013
Time: 10:00am EST/3:00pm GMT

Formedix will be participating in the upcoming webcast titled “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”. The joint webcast comes as a result of the ongoing partnership with Perceptive Informatics, the eClinical solutions provider to deliver an integration between the Formedix Platform and DataLabs EDC which further extends the Formedix Transform product range and allows customers to build and deploy studies from within one tool.

The webcast will give attendees the opportunity to hear real world examples of a CDISC optimized study-setup, EDC build and submission process. Hearing from two industry experts – Mark Wheeldon, Formedix CEO and Doug Burgener, Product Manager at Perceptive Informatics – attendees will also learn of the importance of utilizing CDISC and clinical trial automation software today.

Topics to be discussed during the webcast include:

  •     End-to-End CDISC models at work: Your Clinical Trials Automated Everywhere
  •     Vendor Neutral Libraries: Maximize What You've Got, Again & Again from Start-up to Submission
  •     Optimized Study Set-up: CDISC to Specification Automatically reducing set-up by over 68%
  •     Streamlined EDC build: EDC build times reduced by over 55% and rising...

Formedix CEO, Mark Wheeldon, explains “
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
2. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
3. Pittcon and Food Safety Tech Announce Strategic Conference Partnership
4. Direct Marketing Partners Wins Sales Lead Management’s “Most Influential” in 2012
5. RegLink News Partners with FOI Services on Off-Label Use Teleconference
6. Life Solutions Advocates Announces New Partnerships in Health Promotion and Disease Prevention Initiative
7. CSL Behring Partners with Pro Supercross Racer Carl Schlacht to Encourage Those with Primary Immunodeficiency to be a "ChamPIon"
8. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
9. Veterinary Bioscience Institute (VBI) and a-tune software, Inc. Partnership
10. Chimerix To Present At Therapeutic Area Partnerships Meeting
11. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... May 21, 2013 Possible mold re-infestation in ... according to a report from eagletribune.com posted May 14, 2013, ... case the result is positive, My Cleaning Products offered a ... chemical ingredients. , It was said in the Eagle Tribune ... in the campus sparked after a first-grade classroom was closed ...
(Date:5/21/2013)... Clinovo's new “CDISC Standards: Theory and ... on June 11th, 2013. The TechTrainings are technical hands-on ... next step in their professional career. The class will ... streamed online. , Taught by Sy Truong, President at ... Standards: Theory and Application” class will give an overview ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3Clinovo Launches TechTrainings on CDISC Standards 2
... have succeeded in changing the genetic material of cancer ... in nanosurgery opens the door to new medical applications, ... A light scalpel to treat cancerous cells, The ... team uses a femtosecond laser (a laser with ultra-short ...
... GeneLink Biosciences, Inc. (OTCBB: GNLK), a leading consumer ... the stock of its wholly owned direct-selling subsidiary ... (OTCBB: WELL), another public company operating in the ... and Capsalus executed definitive agreements for the sale ...
... 2012 Senior analysts from The Advisory Board Company,s ... Vegas preparing to provide an immediate analysis of the ... Management Systems Society,s HIMSS12 Annual Conference and Exhibition, which ... http://photos.prnewswire.com/prnh/20110802/PH45999LOGO ) By Monday, the ...
Cached Biology Technology:GeneLink Biosciences Completes Sale of GeneWize Life Sciences 2Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy 2Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy 3
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/18/2013)... (May 18, 2013) An increasing number of ... interventions to resolve, according to research presented at ... study targeting obesity, researchers at the Cleveland Clinic ... unique pattern of exhaled breath compared to their ... organic compound levels that can be correlated to ...
(Date:5/17/2013)... the white noise of the South, but the night belongs ... air hangs heavy from the humidity and the sounds of ... species of frogs, toads and salamanders, is the center of ... swamps are the auditorium for their symphonic choruses, the scientists ... or ARMI, have front-row seats. , Amphibians, which ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... different gene mutations, but just how these mutations contribute to ... new clue comes from scientists at the University of North ... Their research indicates that early life sun exposure, from birth ... melanomas with BRAF gene mutations. A different mutation, on the ...
... were estimated to be living with Alzheimer’s disease in 2006, ... Hopkins Bloomberg School of Public Health. The researchers also concluded ... than 106 million by 2050. By that time, 43 percent ... to that of a nursing home. The findings were presented ...
... at x-rays of hands, searching out the telltale signs of ... arthritis. With these clinical features at his side, he turns ... genome – to figure out what makes these people susceptible ... finally closed the circle between key genes identified in his ...
Cached Biology News:Sun exposure early in life linked to specific skin cancer gene mutation 2Alzheimer's disease to quadruple worldwide by 2050 2Breakthrough developments in rheumatoid arthritis reported 2Breakthrough developments in rheumatoid arthritis reported 3Breakthrough developments in rheumatoid arthritis reported 4
Form: Ready to use Applications: ELISA...
Request Info...
Form: Concentrated Applications: ELISA...
Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF Protein Family: Coagulation, Serine Protease Regulators...
Biology Products: